28 August 2018
Visiongain’s new report Global Clinical Trial Supply Market Analysis: Manufacturing, Logistics and Distribution, Supply Chain Management, Packaging, Cold Chain Logistics indicates that the global clinical trial supply and logistics market will see $20.7bn in spending in 2021.
The Global Clinical Trial Supply and Logistics Market is expected to grow at a CAGR of 7.0% from 2016-2021 and CAGR of 5.6% from 2021-2027. The market is expected to grow at a CAGR of 6.2% from 2016 to 2027. The market is estimated at $14.84bn in 2016 and $28.75bn in 2027.
The lead analyst of the report said: “Drug development trends that will affect the clinical trial supply and logistics market in that period include greater biological and orphan drug development. Moreover, demand for clinical-stage cold chain logistics will grow strongly to 2027. Rising need for cold chain logistics will increase demand for new packaging and monitoring technologies that offer lower-cost solutions, including reusable packaging and phase change materials that allow cooling for more-specific temperature ranges.
Clinical trial supply and logistics submarkets in emerging countries will grow faster from 2017, driven by further off-shoring and globalisation of clinical trials by multinational pharmaceutical companies. In the period of 2016-2027, the Chinese clinical trial supply and logistics submarket will grow with a CAGR of 10.8%.”
The 205-page report contains 120 charts that add visual analysis in order to explain the developing trends within the Global Clinical Trial Supply and Logistics Market.
Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the leading segments: Manufacturing – also with sub forecasting for packaging and for other production, Logistics and distribution – also with sub forecasts for cold chain logistics and for other services and Supply chain management.
The 205-page report offers market forecasts for the United States (US), Germany, France, the United Kingdom, Italy, Spain, Japan, Brazil, Russia, China, India and Rest of the World.
This report discusses the regulatory outlook for the clinical trial supply chain in the national markets. It also assesses the outlook for cold chain logistics in the clinical trial sector, as well as regulatory aspects of cold chain distribution for clinical trial materials
Moreover, this report provides qualitative analysis of the clinical trial supply and logistics market and profiles the leading companies offering clinical trial supply and logistics services to the pharmaceutical industry. This report also provides a full transcript of one interview conducted by visiongain with Marken, US.
The report Global Clinical Trial Supply and Logistics Market for Pharma 2017-2027: Manufacturing, Logistics and Distribution, Supply Chain Management, Packaging, Cold Chain Logistics report will be of value to anyone who wants to better understand the clinical trial supply and logistics market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the clinical trial supply and logistics market.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.
19 October 2020
The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.
12 October 2020
We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
02 October 2020
The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential.